These findings emphasize the role of metabolic health in influencing the course and severity of PsA. The authors emphasize ...

The American College of Rheumatology has updated its systemic lupus erythematosus treatment guidelines for the first time ...

Medically reviewed by Stella Bard, MD It's possible to develop psoriatic arthritis (PsA) without psoriasis, a related chronic (long-lasting) skin condition that usually develops first. How Common Is ...

Typically, psoriatic arthritis affects the toes and fingers, and in time, can lead to disfigurement if not properly treated. Diagnosing psoriatic arthritis is a multi-step process. Doctors will first ...

Deucravacitinib met its primary endpoint of more than 20% improvement in ACR20 response among patients with psoriatic ...

Patients with psoriatic arthritis (PsA) have a higher prevalence of diabetes mellitus (DM) compared to the general population ...

There’s a stronger relationship between psoriasis and psoriatic arthritis. It’s estimated that between 20 and 30 percent of people with psoriasis also have psoriatic arthritis. [ 5 ] ...

Metabolic syndrome is common in psoriatic arthritis and is a known risk factor for worse symptoms and poor treatment outcomes ...

Objective To identify clusters of peripheral involvement according to the specific location of peripheral manifestations (ie, arthritis, enthesitis and dactylitis) in patients with spondyloarthritis ...

Objective To evaluate the efficacy and safety of an oral selective tyrosine kinase 2 (TYK2) inhibitor, deucravacitinib, in patients with active psoriatic arthritis (PsA). Methods In this double-blind, ...

About 8 million Americans have psoriasis—up to 30% of people with psoriasis develop psoriatic arthritis. Psoriatic arthritis can be mild or severe, and it may involve one or many of your joints.